Form 4 for ASTH Astrana Health, Inc.
Accepted 2021-11-04 00:00:00 ET · period of report 2021-11-02 · accession 0001628280-21-021868 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-04 | 2021-11-02 | ASTH | Sim Brandon | Co-CEO | A - Grant | $0.00 | +42.5K | 184.1K | +30% | $0 |
| D | 2021-11-04 | 2021-11-02 | ASTH | Sim Brandon | Co-CEO | A - Grant | $0.00 | +54.5K | 54.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-02 | A | A | 42,451 | $0.00 | 184,063 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2021-11-02 | A | A | 54,486 | $0.00 | 54,486 | D | $80.00 · — to 2026-11-02 | 54,486 Common Stock | (F1) Provided the Reporting Person is still employed with the Issuer on the following dates, the option shall vest in three equal annual installments commencing on the first anniversary of November 2, 2021. |